U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07338682) titled 'Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients' on Jan. 04.
Brief Summary: This study aims to evaluate the effect of L-arginine supplementation on cognitive function in geriatric patients. Eligible participants will receive either L-arginine (6 grams once daily) or placebo, and their cognitive performance will be assessed using validated cognitive assessment tools over the study period. The participants will receive the intervention for 4 weeks and followed up every 2 weeks. The primary outcome is improvement in cognitive function, while secondary outcomes include safety, tolerability, and qua...